Effects of expectancies on subjective responses to oral Δ-tetrahydrocannabinol

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 287-293

  Kirk, J M ^a   Doty, Pamela ^b   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b CATO RESEARCH LTD   (United States)

Author keywords

9 THC; Cannabinoids; Expectancies; Marijuan users; Subjective drug effects

Indexed keywords

CANNABINOID; CANNABIS; PLACEBO;

ADDICTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; EXPECTANCY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; EUPHORIA; FEMALE; HALLUCINOGENS; HEART RATE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SET (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL;

EID: 0032006542     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00414-0     Document Type: Article

References (14)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4:1994;American Psychiatric Association, Washington, DC.
2. Chait L. D., Evans S. M., Grant K. A., Kamien J. B., Johanson C. E., Schuster C. R. Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology (Berlin). 94:1988;206-212.
3. Chait L. D., Zacny J. Reinforcing and subjective effects of oral delta-9-THC and smoked marijuana in humans. Psychopharmacology (Berlin). 107:1992;255-262.
4. 9-tetrahydrocannabinol in man on mood and performance measures. A dose-response study Pharmacol. Biochem. Behav. 35:1990;861-864.
5. Compton D. R., Harris A. H., Lichtman A. H., Martin B. R. Marihuana. Schuster C. R., Kuhar M. J. Pharmacological aspects of drug dependence. Toward an integrative neurobehavioral approach:1995;83-158 Springer Verlag, Berlin.
6. Derogatis L. SCL-90-R manual - II. 1983;Clinical Psychometric Research, Towson, MD.
7. de Wit, H.; Kirk, J. M.; Justice, A.: Behavioral pharmacology of cannabinoids. In: Tarter, R. E.; Ammerman, R. T.; Ott, P. J., eds. Sourcebook on substance abuse: Etiology, methodology, and intervention. New York: Allyn & Bacon; (in press).
8. Griffiths R. R., Woodson P. P. Reinforcing effects of caffeine in humans. J. Pharmacol. Exp. Ther. 246:1988;21-29.
9. Haertzen C. H., Hickey J. E. Addiction research center inventory (ARCI). Measurement of euphoria and other drug effects Bozarth M. A. Methods of assessing the reinforcing properties of abused drugs. 1987;489-524 Springer-Verlag, New York.
10. Marlatt G. A., Rohsenow D. J. Cognitive processes in alcohol use. Expectancy and the balanced placebo design Mello N. K. Advances in substance abuse. 1980;JAI Press, Greenwich, CT.
11. 9-tetrahydrocannabinol, smoked marijuana, and nabilone. Influence of previous marijuana use Psychopharmacology (Berlin). 83:1984;351-356.
12. Mitchell S. H., Laurent C. L., de Wit H. Interaction of expectancy and the pharmacological effects of d-amphetamine. Subjective effects and self-administration Psychopharmacology (Berlin). 125:1996;371-378.
13. Stern K. N., Chait L. D., Johanson C. E. Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology (Berlin). 98:1989;81-88.
14. Wechsler D. The measure and appraisal of adult intelligence. 1958;Williams and Wilkins, Baltimore, MD.